Company intelligence / Profile preview

Noventure

Barcelona, Catalonia, Spainnoventure.com ↗

Ownership: Private
Development stage: Commercial

Overview

Noventure develops and licenses innovative substance-based medical devices and specialized food supplements with international patents. Their products have solid scientific backing from reputable journals. The company operates through a network of partners/distributors in 45 countries across multiple continents. In 2021, they acquired Ulkox and Oleoabrax—medical devices based on patented Olea Europaea leaf extract technology for wound healing. Clinical results per product are not publicly detailed.

Therapeutic areas: OtherGastroenterologyDermatologyWomen's Health
Modalities: DeviceFood supplementNutraceutical
Industry: Consumable Medical Devices

Drug pipeline

2 assets

Ulkox

Commercial

Indications: Wound healing, Skin ulcers

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Noventure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noventure.

Explore the full profile